David FitzGerald

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 2

Top Topics

Monoclonal Antibody

Tyrosine Kinase

Epidermal Growth Factor Receptor

Induced Pluripotent Stem Cells

Top Venues

Antibody therapeutics

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute

United States

Principal Investigator :: Laboratory of Molecular Biology

Publications

Antonella Antignani, Maria Teresa Bilotta, Jacob S Roth, Daniel J Urban, Min Shen, Matthew D Hall, David FitzGerald
Birinapant selectively enhances immunotoxin-mediated killing of cancer cells conditional on the IAP protein levels within target cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (12) (2023)
Eric Chun Hei Ho, Antonella Antignani, Robert Sarnovsky, David FitzGerald
'Characterization of monoclonal antibodies generated to the 287-302 amino acid loop of the human epidermal growth factor receptor'. Antibody therapeutics 2 (4) (2019)